Beta Thalassemia Treatment Market - Top Companies and Manufacturers

Companies Dominating the Beta Thalassemia Treatment Market

Bluebird Bio Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
Vertix Pharmaceuticals Incorporated
ApoPharma Inc.

Browse Key Market Insights with Data Illustration:

Beta Thalassemia Treatment Market Size, Growth Statistics 2037

In the News

Zynteglo, a new generation of gene therapy for adult and paediatric patients with beta thalassemia that requires regular red cell transfusions, has been authorised by the US Food and Drug Administration.
CRISPR and Vertex Pharmaceuticals Incorporated announced the Fast Track Designation for CTX001 to treat transfusiondependent beta thalassemia has been given by the United States Food and Drug Administration. CTX001 is an investigational autologous, gene edited therapy of hematopoietic stem cells for patients with severe hemoglobinopathies.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of beta thalassemia treatment is assessed at USD 556.56 million.

The beta thalassemia treatment market size was over USD 523.48 million in 2024 and is likely to reach USD 1.4 billion by the end of 2037, witnessing around 7.9% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of beta thalassemia and increasing healthcare expenditure will boost the market growth.

North America industry is set to dominate majority revenue share 33% by 2037, backed by increasing presence of key players in the region.

The major players in the market are of Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company, Vertix Pharmaceuticals Incorporated, and others.

Beta Thalassemia Treatment Market - Top Companies and Manufacturers

Companies Dominating the Beta Thalassemia Treatment Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the beta thalassemia treatment market worth?

Why is the demand for beta thalassemia treatment growing?

Which region dominated the majority of beta thalassemia treatment industry share?

Who are the top beta thalassemia treatment companies?